Intracoronary infusions and the assessment of coronary blood flow in clinical studies

Por NEWBY, D.
Publicado em 2000

Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer?

Por Burdess, A, Newby, D
Publicado em 2006

Therapeutic inhibition of tumour necrosis factor α in patients with heart failure: cooling an inflamed heart

Por Henriksen, P A, Newby, D E
Publicado em 2003

The endothelin system in cardiovascular disease.

Por Newby, D. E., Webb, D. J.
Publicado em 1997

Comparison of 2,4-Dichlorophenoxyacetic Acid Degradation and Plasmid Transfer in Soil Resulting from Bioaugmentation with Two Different pJP4 Donors

Por Newby, D. T., Gentry, T. J., Pepper, I. L.
Publicado em 2000

Real-Time PCR Detection of Brucella abortus: a Comparative Study of SYBR Green I, 5′-Exonuclease, and Hybridization Probe Assays

Por Newby, D. T., Hadfield, T. L., Roberto, F. F.
Publicado em 2003

Detection and Characterization of Plasmid pJP4 Transfer to Indigenous Soil Bacteria

Por Newby, D. T., Josephson, K. L., Pepper, I. L.
Publicado em 2000

Losartan and renal sodium handling

Por JALAN, R, NEWBY;, D, WONG, F, BLENDIS, L
Publicado em 2000

Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?

Por Newby, D E, Cowell, S J, Boon, N A
Publicado em 2006

Endothelin antagonism in pulmonary hypertension, heart failure, and beyond

Por Attinà, T, Camidge, R, Newby, D E, Webb, D J
Publicado em 2005

Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery

Por Prendergast, B, Newby, D, Wilson, L, Webb, D, Mankad, P
Publicado em 1999

Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease

Por Robinson, S D, Ludlam, C A, Boon, N A, Newby, D E
Publicado em 2006

Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats.

Por Newby, D. E., Neilson, J. M., Jarvie, D. R., Boon, N. A.
Publicado em 1996

Enalapril overdose and the corrective effect of intravenous angiotensin II.

Por Newby, D E, Lee, M R, Gray, A J, Boon, N A
Publicado em 1995

Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II

Por Newby, D, Goodfield, N, Flapan, A, Boon, N, Fox, K, Webb, D
Publicado em 1998

Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide

Por Helmy, A, Newby, D E, Jalan, R, Hayes, P C, Webb, D J
Publicado em 2003

Estimates of Biogenic Methane Production Rates in Deep Marine Sediments at Hydrate Ridge, Cascadia Margin

Por Colwell, F. S., Boyd, S., Delwiche, M. E., Reed, D. W., Phelps, T. J., Newby, D. T.
Publicado em 2008

Radial artery vasomotor function following transradial cardiac catheterisation

Por Mitchell, A J, Mills, N L, Newby, D E, Cruden, N L M
Publicado no Open Heart (2016)

Endothelin‐1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial

Por Tripathi, D, Therapondos, G, Ferguson, J W, Newby, D E, Webb, D J, Hayes, P C
Publicado em 2006

Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites

Por Ferguson, J W, Dover, A R, Chia, S, Cruden, N L M, Hayes, P C, Newby, D E
Publicado em 2006